Consolidated Balance Sheet (Unaudited) (USD $) In Millions, unless otherwise specified	Jun. 30, 2014		Dec. 31, 2013
Assets
Cash and due from banks	$ 12,636		$ 8,477
Investment securities
Held-to-maturity (fair value $41,964 and $38,368, respectively; including $528 and $994 at fair value pledged as collateral, respectively)	41,995	[1]	38,920	[1]
Available-for-sale ($149 and $1,106 pledged as collateral, respectively)	48,389	[1]	40,935	[1]
Loans held for sale (including $2,994 and $3,263 of mortgage loans carried at fair value, respectively)	3,018		3,268
Loans
Commercial	77,454		70,033
Commercial real estate	40,797		39,885
Residential mortgages	51,965		51,156
Credit Card	17,642		18,021
Other retail	48,568		47,678
Total loans, excluding covered loans	236,426		226,773
Covered loans	7,448		8,462
Total loans	243,874		235,235
Less allowance for loan losses	(4,132)		(4,250)
Net loans	239,742		230,985
Premises and equipment	2,614		2,606
Goodwill	9,422		9,205
Other intangible assets	3,337		3,529
Other assets (including $265 and $111 of trading securities at fair value pledged as collateral, respectively)	27,912	[1]	26,096	[1]
Total assets	389,065		364,021
Deposits
Noninterest-bearing	80,266		76,941
Interest-bearing	166,531		156,165
Time deposits greater than $100,000	29,465		29,017
Total deposits	276,262		262,123
Short-term borrowings	29,101		27,608
Long-term debt	25,891		20,049
Other liabilities	14,425		12,434
Total liabilities	345,679		322,214
Shareholders' equity
Preferred stock	4,756		4,756
Common stock, par value $0.01 a share - authorized: 4,000,000,000 shares; issued: 6/30/14 and 12/31/13 -2,125,725,742 shares	21		21
Capital surplus	8,264		8,216
Retained earnings	40,573		38,667
Less cost of common stock in treasury: 6/30/14 - 316,910,538 shares; 12/31/13 - 300,977,274 shares	(10,232)		(9,476)
Accumulated other comprehensive income (loss)	(682)		(1,071)
Total U.S. Bancorp shareholders' equity	42,700		41,113
Noncontrolling interests	686		694
Total equity	43,386		41,807
Total liabilities and equity	$ 389,065		$ 364,021

[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.